Single User License
INR 102555
Site License
INR 205110
Corporate User License
INR 307665

Service Tax Additional

select a format
Price

Single User License
USD 1500
Site License
USD 3000
Corporate User License
USD 4500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Neurocrine Biosciences, Inc.-Product Pipeline Review-2015

Neurocrine Biosciences, Inc.-Product Pipeline Review-2015


  Request for Sample Report

Executive Summary

Neurocrine Biosciences, Inc.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Neurocrine Biosciences, Inc.-Product Pipeline Review-2015', provides an overview of the Neurocrine Biosciences, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Neurocrine Biosciences, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Neurocrine Biosciences, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Neurocrine Biosciences, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Neurocrine Biosciences, Inc.'s pipeline products

Reasons To Buy

Evaluate Neurocrine Biosciences, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Neurocrine Biosciences, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Neurocrine Biosciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Neurocrine Biosciences, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Neurocrine Biosciences, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Neurocrine Biosciences, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Neurocrine Biosciences, Inc. Snapshot 5

Neurocrine Biosciences, Inc. Overview 5

Key Information 5

Key Facts 5

Neurocrine Biosciences, Inc.-Research and Development Overview 6

Key Therapeutic Areas 6

Neurocrine Biosciences, Inc.-Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products-Monotherapy 10

Pipeline Products-Out-Licensed Products 11

Out-Licensed Products/Combination Treatment Modalities 12

Neurocrine Biosciences, Inc.-Pipeline Products Glance 13

Neurocrine Biosciences, Inc.-Late Stage Pipeline Products 13

Phase III Products/Combination Treatment Modalities 13

Neurocrine Biosciences, Inc.-Clinical Stage Pipeline Products 14

Phase II Products/Combination Treatment Modalities 14

Phase I Products/Combination Treatment Modalities 15

Neurocrine Biosciences, Inc.-Early Stage Pipeline Products 16

Preclinical Products/Combination Treatment Modalities 16

Discovery Products/Combination Treatment Modalities 17

Neurocrine Biosciences, Inc.-Drug Profiles 18

valbenazine 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

verucerfont 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Small Molecule to Inhibit VMAT-2 for Schizophrenia, Bipolar Disorder and Movement Disorders 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Small Molecules for CNS Disorders 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Small Molecules to Agonize GPR119 for Type 2 Diabetes 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

Small Molecules to Antagonize GPCR for Central Nervous System Diseases 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

Neurocrine Biosciences, Inc.-Pipeline Analysis 26

Neurocrine Biosciences, Inc.-Pipeline Products by Target 26

Neurocrine Biosciences, Inc.-Pipeline Products by Route of Administration 27

Neurocrine Biosciences, Inc.-Pipeline Products by Molecule Type 28

Neurocrine Biosciences, Inc.-Pipeline Products by Mechanism of Action 29

Neurocrine Biosciences, Inc.-Recent Pipeline Updates 30

Neurocrine Biosciences, Inc.-Dormant Projects 34

Neurocrine Biosciences, Inc.-Discontinued Pipeline Products 35

Discontinued Pipeline Product Profiles 35

tiplimotide 35

indiplon 35

prasterone 35

Neurocrine Biosciences, Inc.-Company Statement 36

Neurocrine Biosciences, Inc.-Locations And Subsidiaries 37

Head Office 37

Other Locations & Subsidiaries 37

Appendix 38

Methodology 38

Coverage 38

Secondary Research 38

Primary Research 38

Expert Panel Validation 38

Contact Us 38

Disclaimer 39

List of Tables

Neurocrine Biosciences, Inc., Key Information 5

Neurocrine Biosciences, Inc., Key Facts 5

Neurocrine Biosciences, Inc.-Pipeline by Indication, 2015 8

Neurocrine Biosciences, Inc.-Pipeline by Stage of Development, 2015 9

Neurocrine Biosciences, Inc.-Monotherapy Products in Pipeline, 2015 10

Neurocrine Biosciences, Inc.-Out-Licensed Products in Pipeline, 2015 11

Neurocrine Biosciences, Inc.-Out-Licensed Products/ Combination Treatment Modalities, 2015 12

Neurocrine Biosciences, Inc.-Phase III, 2015 13

Neurocrine Biosciences, Inc.-Phase II, 2015 14

Neurocrine Biosciences, Inc.-Phase I, 2015 15

Neurocrine Biosciences, Inc.-Preclinical, 2015 16

Neurocrine Biosciences, Inc.-Discovery, 2015 17

Neurocrine Biosciences, Inc.-Pipeline by Target, 2015 26

Neurocrine Biosciences, Inc.-Pipeline by Route of Administration, 2015 27

Neurocrine Biosciences, Inc.-Pipeline by Molecule Type, 2015 28

Neurocrine Biosciences, Inc.-Pipeline Products by Mechanism of Action, 2015 29

Neurocrine Biosciences, Inc.-Recent Pipeline Updates, 2015 30

Neurocrine Biosciences, Inc.-Dormant Developmental Projects,2015 34

Neurocrine Biosciences, Inc.-Discontinued Pipeline Products, 2015 35

Neurocrine Biosciences, Inc., Subsidiaries 37

List of Figures

Neurocrine Biosciences, Inc.-Pipeline by Top 10 Indication, 2015 7

Neurocrine Biosciences, Inc.-Pipeline by Stage of Development, 2015 9

Neurocrine Biosciences, Inc.-Monotherapy Products in Pipeline, 2015 10

Neurocrine Biosciences, Inc.-Out-Licensed Products in Pipeline, 2015 11

Neurocrine Biosciences, Inc.-Pipeline by Top 10 Target, 2015 26

Neurocrine Biosciences, Inc.-Pipeline by Top 10 Route of Administration, 2015 27

Neurocrine Biosciences, Inc.-Pipeline by Top 10 Molecule Type, 2015 28

Neurocrine Biosciences, Inc.-Pipeline Products by Top 10 Mechanism of Action, 2015 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Neurocrine Biosciences, Inc.; Neurocrine Biosciences, Inc. - Key Therapeutics; Neurocrine Biosciences, Inc. - Pipeline Overview and Promising Molecules; Neurocrine Biosciences, Inc. - News; Neurocrine Biosciences, Inc. - Latest Updates; Neurocrine Biosciences, Inc. - Pipeline; Neurocrine Biosciences, Inc. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com